Summary
This Nature paper describes a novel class of antibiotics that target the lipopolysaccharide transport (Lpt) machine in Gram-negative bacteria, specifically Acinetobacter. Through structural, biochemical and genetic analysis, the authors demonstrate that these inhibitors work by trapping a substrate-bound conformation of the transporter, exploiting a composite binding site formed by both the Lpt protein complex and its LPS substrate. The findings establish a new mechanism of lipid transport inhibition and provide a foundation for developing this antibiotic class against other Gram-negative pathogens.
UK applicability
This fundamental research on bacterial cell envelope mechanisms and antibiotic resistance has potential long-term relevance to antimicrobial stewardship in the United Kingdom, particularly for treating infections caused by challenging Gram-negative pathogens. However, the work is basic science; clinical translation and regulatory pathways would require substantial further development.
Key measures
Binding interactions between antibiotics and the Lpt transporter-LPS complex; transporter conformation states; inhibition of LPS transport machinery
Outcomes reported
The study characterised a new class of antibiotics that inhibit lipopolysaccharide (LPS) transport in Gram-negative bacteria, specifically by trapping a substrate-bound conformation of the LPS transporter. The research used structural, biochemical and genetic approaches to elucidate the mechanism of inhibition and identify a druggable conformation of the Lpt transporter.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.